Keith Wells

Hematology | Oncology
444 Nw Elks Dr
Corvallis, OR 97330

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.

Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy.

Journal: Cancers
Published: May 30, 2020

Gender differences in melanoma prognostic factors.

Gender differences in melanoma prognostic factors.

Journal: Dermatology online journal
Published: June 12, 2018

Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience.

Greater distance to an academic medical center is associated with poorer melanoma prognostic factors: The University of Colorado Experience.

Journal: Dermatology online journal
Published: December 08, 2017

ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.

ALK Inhibitor Response in Melanomas Expressing EML4-ALK Fusions and Alternate ALK Isoforms.

Journal: Molecular cancer therapeutics
Published: May 22, 2017

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Journal: Melanoma research
Published: March 16, 2017

Kinase gene fusions in defined subsets of melanoma.

Kinase gene fusions in defined subsets of melanoma.

Journal: Pigment cell & melanoma research
Published: July 08, 2016
Showing 1-6 of 6

Last Updated: 09/26/2026